Department of Molecular Pathology, Faculty of Life Science, Kumamoto University Graduate School, Kumamoto, Japan.
Eur J Haematol. 2011 May;86(5):436-41. doi: 10.1111/j.1600-0609.2011.01585.x. Epub 2011 Apr 1.
We have demonstrated that the cross-linking of ribosomal protein S19 (RP S19) on platelets by activated factor XIII provides chemotactic potency to monocytes/macrophages for a resolution of coagulum. Factor XIII is activated by an active form of prothrombin, thrombin. We here report that RP S19 is present as a complex with prothrombin in the blood stream. Formation of this complex was blocked by a mutation of the glycosaminoglycan-binding basic cluster (Lys(23) -Lys(29) ) in RP S19. Prothrombin-RP S19 interaction was enhanced by an absence of Ca(2+) and the plasma RP S19 concentration was significantly low in the patient treated with warfarin, indicating participation of the γ-carboxyl glutamic acid domain of prothrombin making a salt bridge with the basic cluster. The complex formation likely explains why a protein as small as RP S19 can prevent from a filtering system of renal glomeruli at a steady state. The translocation of RP S19 from prothrombin to platelets during blood coagulation seems to be also advantageous for RP S19 from the perspective of oligomerisation by activated factor XIII, which should have been activated by thrombin.
我们已经证明,血小板中被激活的因子 XIII交联核糖体蛋白 S19(RP S19)为单核细胞/巨噬细胞提供趋化潜能,以溶解血栓。因子 XIII 通过凝血酶原的一种活性形式激活。我们在此报告,RP S19 以与血液中的凝血酶原形成复合物的形式存在。该复合物的形成被 RP S19 中糖胺聚糖结合碱性簇(Lys(23)-Lys(29))的突变所阻断。缺乏 Ca(2+)可增强凝血酶原-RP S19 相互作用,且华法林治疗患者的血浆 RP S19 浓度明显降低,表明凝血酶原的 γ-羧基谷氨酸结构域与碱性簇形成盐桥。这种复合物的形成可能解释了为什么像 RP S19 这样小的蛋白质在稳定状态下也能防止被肾脏肾小球的过滤系统滤过。在血液凝固过程中,RP S19 从凝血酶原转移到血小板,这似乎也有利于被激活的因子 XIII 聚合的 RP S19,因为因子 XIII 应该已经被凝血酶激活了。